Analyst Ratings for Acceleron Pharma (XLRN) [Buys]

XLRN Rating Summary

XLRN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on XLRN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $152.00 (+20.5%) * Over Last 12-Mos
Rating Score: 8.1 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/12/2021 Wolfe Research Akash Tewari New Coverage Outperform
(N/A)
200.00
(N/A)
128.94
(126.09)
-2.21% Details
8/25/2020 Raymond James
» Updated 1/19/2021
Danielle Brill New Coverage Strong Buy
(N/A)
160.00
(155.00)
93.38
(126.09)
35.03% Details
Like XLRN Ratings? Also take a look at BMY

XLRN Ratings News